Skip to main content
. 2018 Sep 14;18:892. doi: 10.1186/s12885-018-4807-6

Table 4.

Association with frailty index

Assessments N = 175 FI median (IQR) Effect Size p value
VES Assessment
 Not vulnerable 112 (64.0%) 0.24 (0.19–0.29) r = 0.67 < 0.001
 Vulnerable 63 (36.0%) 0.42 (0.36–0.52)
Dr Assessment
 Fit 90 (53.3%) 0.24 (0.19–0.32) Reference
 Vulnerable 52 (30.8%) 0.30 (0.22–0.43) r = 0.29 0.001
 Frail 27 (16.0%) 0.38 (0.29–0.61) r = 0.43 < 0.001
Treatment Decisions N = 175 FI median (IQR) OR (95% CI)
Treatment plan
 Completed 46 (26.9%) 0.24 (0.15–0.35) 1.65 (1.32–2.05) < 0.001
 Terminated 94 (55.0%) 0.27 (0.21–0.36)
 Not planned 31 (18.1%) 0.40 (0.30–0.56)
Drug alteration
  < 10% 87 (61.7%) 0.27 (0.21–0.35) 0.98 (0.71–1.28) 0.89
  ≥ 10% 54 (38.3%) 0.26 (0.20–0.38)